372910 — Hancom Lifecare Income Statement
0.000.00%
- KR₩64bn
- KR₩29bn
- KR₩92bn
Annual income statement for Hancom Lifecare, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | ARS | ARS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 121,140 | 100,120 | 112,780 | 104,776 | 92,088 |
| Cost of Revenue | |||||
| Gross Profit | 27,949 | 19,885 | 23,739 | 29,134 | 21,411 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 116,439 | 110,546 | 111,661 | 97,287 | 93,337 |
| Operating Profit | 4,701 | -10,426 | 1,119 | 7,489 | -1,249 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 5,594 | 13,236 | 1,625 | 9,082 | -9,374 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4,835 | 9,269 | 871 | 7,336 | -7,666 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 4,835 | 9,204 | 825 | 7,375 | -7,725 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4,835 | 9,204 | 825 | 7,375 | -7,725 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 149 | 556 | 40.6 | 264 | -258 |
| Dividends per Share |